LOGO
LOGO

Breaking News

Trimble Raises 2026 Guidance

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

Trimble Inc. (TRMB) said, for the full-year 2026, it expects to report revenue between $3.835 billion and $3.915 billion, GAAP earnings per share of $2.05 to $2.21, and non-GAAP earnings per share of $3.47 to $3.64. Previously, Trimble projected revenue between $3.81 billion and $3.91 billion, GAAP earnings per share of $2.04 to $2.23, and non-GAAP earnings per share of $3.42 to $3.62. The company expects strong organic growth to continue in fiscal 2026 with continued progression towards $3 billion ARR, $4 billion revenue, 30% EBITDA margins in 2027.

For the second quarter, Trimble expects to report revenue between $938 million and $963 million, GAAP earnings per share of $0.38 to $0.42, and non-GAAP earnings per share of $0.78 to $0.82.

For the first quarter, the company's earnings totaled $98.9 million, or $0.42 per share. This compares with $66.7 million, or $0.27 per share, last year. Non-GAAP net income per share was $0.79 compared to $0.61. First quarter revenue was $939.9 million, up 12 percent on a year-over-year basis, up 12 percent on an organic basis. Annualized recurring revenue or ARR was $2.43 billion, up 12 percent year-over-year, up 12 percent on an organic basis.

In pre-market trading on NasdaqGS, Trimble shares are up 0.73 percent to $68.87.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19